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Abstract
Background: The core symptoms of bulimia nervosa (BN) and binge eating disorder (BED) are recurrent episodes
of binge eating. Despite negative psychological and physical consequences, BN/BED patients show uncontrollable
approach tendencies towards food. This cognitive bias occurs at an early stage of information processing. Cognitive
bias modification (CBM) directly targets such biases and has been shown to be effective in treating several mental
disorders. In alcohol addiction, automatic action tendencies towards alcohol cues and relapse rates were
successfully reduced by a specific form of CBM, termed approach bias modification. Based on these findings and
data from a proof-of-concept study in people with high levels of food craving, CBM is considered a promising new
treatment approach for BN/BED. Given the similarities between BN/BED and addictive disorders, the rationale for
using approach bias modification appears to be particularly strong. The aim of the present study is to examine
whether, compared to a sham training, computerised approach bias modification (10 sessions) can reduce binge-
eating episodes in BN/BED patients from pre-treatment to follow-up. Additionally, we will investigate whether this
CBM programme also reduces global eating disorder psychopathology, trait and cue-elicited food craving, food
intake as well as approach and attentional bias towards visual food cues. Treatment acceptance will be determined
by attrition rates and responses on a feedback form.
Methods: This is a double-blind, randomised, placebo-controlled, parallel-group superiority trial with two parallel
arms. A total of 54 BN/BED patients will be recruited. Approach bias towards food will be retrained by a computer
task adopting an implicit learning paradigm. Patients in the control condition (sham) will conduct a similar task but
will not be trained to avoid food cues. Methods against bias include public registration, randomisation by a central
study office, standardisation of the treatments and blinding of assessors. Furthermore, the session number and
duration will be equivalent in the two conditions.
Discussion: This is the first registered randomised controlled trial of approach bias modification in a clinical BN/BED
sample. Results from this study will provide an indication of the efficacy of approach bias modification training for
BN/BED and the potential mechanisms of action underlying this treatment.
Trial registration: DRKS00010231 (retrospectively registered on 24 March 2016; first version)
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Background
Bulimia nervosa (BN) and binge eating disorder (BED)
are common and serious mental disorders with elevated
all-cause mortality, comorbidity and high relapse rates
[1–4]. They share repeated episodes of binge eating as
key characteristics [5]. Several authors have highlighted
the addiction-like features in BN and BED [6–9] such as
uncontrollable approach tendencies towards binge food
despite significant negative psychological and physical
consequences.
According to dual-process models, two distinct sys-
tems of information processing contribute to the evalu-
ation of food cues and the control of eating behaviour,
i.e. an impulsive system that operates rapidly and auto-
matically (i.e. mostly outside of conscious control), and a
reflective system that operates slower and more deliber-
ately [10, 11]. The impulsive system evaluates food cues
primarily regarding their current emotional and motiv-
ational significance. In contrast, the reflective system in-
volves higher-order processes of cognitive control,
deliberate decisions and impulse regulation that take
long-term consequences into account. It is thought that
in addictive disorders, the impulsive system dominates
to a large degree the initiation of addictive behaviour,
whereas the reflective system lacks power to control this
behaviour [11]. Supporting this assumption, bulimic eat-
ing disorders such as BN and BED are associated with
strong, impulsive responses and poor cognitive control
towards food cues, which is considered to contribute to
a heightened susceptibility to sensitised cues that trigger
action tendencies and lead to binge eating [12]. Hence,
even though people with a bulimic eating disorder may
be aware of the negative consequences of binge eating,
they may still engage in it when food cues are processed
in the impulsive system. This is reflected by findings that
individuals with bulimic eating disorders show appetitive
physical responses towards food cues despite rating
them as anxiety-provoking and disgusting [13, 14]. A
rapidly growing body of research shows that eating dis-
orders and unhealthy eating behaviour are associated
with cognitive biases that unfold their negative effects in
the impulsive system during the automatic processing of
food cues, particularly by increasing attention and ap-
proach tendencies towards food [14–21].
Traditional (talking) psychotherapy programmes may
not be best suited to directly modulate such biases that
occur at an early stage in information processing and that
often operate outside of conscious control [11, 22, 23]. In
an effort to create more suitable interventions, researchers
have translated findings from basic research and devel-
oped cognitive bias modification (CBM) programmes that
are considered to provide a way to more directly target
such biases. Different CBM programmes have been shown
to be effective in treating mental disorders such as
depression [24], social phobia [25] and addictive disorders
[26–29]. With regards to the latter, several studies have
used an approach bias modification training in alcohol-
dependent participants and found this to effectively re-
duce automatic action tendencies towards alcohol cues
and relapse rates [27, 29, 30]. Several meta-analyses have
demonstrated the efficacy of CBM across different mental
disorders [31–35]. Consequently, CBM has also been sug-
gested as a potential new treatment approach for eating
disorders [22, 23]. Recently, it was shown that approach
bias modification reduces approach bias towards food
cues and actual food intake in female student populations
[36, 37]. However, it is yet unknown whether such a train-
ing is equally effective in clinical samples of patients with
BN/BED. In addition, the efficacy may also depend on the
use of multiple sessions of training [38].
In a proof-of-concept study [39] we recently evaluated
the efficacy of such an approach bias modification train-
ing in a sample of people with high levels of food craving
and subthreshold bulimic symptoms. Both the targeted
approach bias towards food cues and also attentional
bias towards food, trait and cue-elicited food craving, as
well as more general eating disorder symptoms, were
significantly reduced during the training with medium to
large effect sizes in this study. The initial approach bias
towards visual food cues was not only reduced (as
hypothesised) but actually turned into an avoidance bias.
Furthermore, all participants completed the intervention
and the majority of them perceived the training as
effective in altering daily eating habits. Taken together,
these highly promising findings suggested that retraining
automatic action tendencies in people with bulimic
symptoms by means of computerised CBM may be an
effective, feasible and acceptable way of reducing cogni-
tive biases, food craving and binge eating. Thus, a rando-
mised controlled trial with BN and BED patients
appeared to be the logical next step.
According to the emotional distress hypothesis of
binge eating, cognitive biases constitute latent vulner-
ability factors that become evident when the individ-
ual is confronted with a stressor [40]. Consequently,
CBM should be most effective in its impact on cogni-
tive biases and subsequent eating behaviour upon ex-
posure to stressful situations. In fact, it has been
demonstrated that CBM attenuates the effects of
stressors on symptoms of depression and anxiety [41, 42].
Furthermore, there is a common theoretical basis and
strong empirical evidence that negative affect (in re-
sponse to a stressor) is a key trigger of attentional
bias towards food and of binge eating [43–46]. There-
fore, we applied a vulnerability-stress model for our
CBM programme by using stimuli that induce moder-
ate levels of negative affect before cognitive bias
training and assessment.
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Aims
The central aim of this randomised controlled pilot trial
is to examine whether a specifically tailored, brief (10
sessions), computerised CBM training (approach bias
modification versus sham) is able to reduce binge-eating
episodes in BN and BED patients (primary efficacy end-
point). More precisely, from pre-treatment to 2-month
follow-up, BN and BED patients who receive real CBM
are expected to report a greater reduction in the number
of objective binge-eating episodes during the previous
2 months than those who receive sham CBM.
Additionally, we will investigate whether this CBM
programme reduces global eating disorder psychopath-
ology from pretreatment to follow-up, and trait and cue-
elicited food craving, food intake and approach and
attentional bias towards visual food stimuli in BN and
BED patients from pre- to post-treatment. Finally, we
will assess treatment acceptance by attrition rates and by
means of a specifically designed feedback form. Specific-
ally, as compared to patients in the sham CBM condi-
tion, patients in the real CBM condition are expected to
show (1) decreased global eating disorder psychopath-
ology from pre-treatment to follow-up, (2) decreased
approach and attentional bias towards food cues, (3) de-
creased state food craving after cue exposure, (4) de-
creased trait food craving as well as (5) reduced food
intake in a bogus taste test from pre- to post-treatment.
In an exploratory analysis we will examine the patients’
acceptance of this specific CBM intervention, taking
dropout rates and scores on a feedback form into ac-
count (treatment acceptance).
Methods
Design
This is a superiority trial adopting a double-blind, rando-
mised, placebo-controlled, parallel-group design comparing
real and sham CBM. Participants with BN or BED will be
randomly allocated to receive either 10 sessions (15 min
each) of real CBM (treatment group) or sham CBM (con-
trol group) in a period of 4 weeks. Participants will be re-
cruited from two different sites (Heidelberg, Germany and
London, UK). Outcomes will be assessed at baseline, post-
treatment and 2-month follow-up. The study protocol is
outlined in the flow chart in Fig. 1, and Table 1 provides de-
tails of all assessments at the different timepoints.
Participants and recruitment
Participants will be recruited from the outpatient units
of the Department of General Internal Medicine and
Psychosomatics at University Hospital Heidelberg, the
South London and Maudsley NHS Foundation Trust’s
Specialist Adult Eating Disorders Unit, and through
websites, circular mails, advertising posters and adver-
tisements in the local media.
Inclusion criteria
Women and men will be eligible for participation if they
are aged 18 years or above and meet the criteria of a
Diagnostic and Statistical Manual of Mental Disorders,
version 5 (DSM-5) diagnosis of BN or BED [5].
Exclusion criteria
Exclusion criteria are: (1) age under 18 years, (2) medical
(e.g. electrolyte abnormalities) or psychiatric (e.g. acute
suicidality) instability, (3) the need for immediate inpatient
treatment, (4) lifetime diagnosis of substance dependence,
psychosis, bipolar disorder, attention deficit hyperactivity
disorder (ADHD) or borderline personality disorder, (5)
psychotropic medication use other than selective sero-
tonin reuptake inhibitors (patients have to be on a stable
medication, i.e. at least 14 days of a SRRI during participa-
tion in the trial), (6) severe learning disability that affects
patients’ ability to complete study assessments/treatment,
and (7) the inability to speak fluent English/German
(depending on study site), impacting on patients ability to
complete study assessments/treatment.
Sample size
Previous randomised controlled trials comparing real
and sham versions of approach bias modification in clin-
ical samples applied a repeated measures ANOVA
design (group × time) to examine treatment-specific
changes and have reported small-to-medium effect sizes
(ηp
2 between 0.05 and 0.06) [27, 29, 30]. Using the smal-
lest effect size that has previously been reported, a total
sample size of 40 patients will have 80 % power to detect
an effect of this size using a 2 × 2 repeated measures
ANOVA with a 0.05 two-tailed significance level. The
percentage of data lost owing to errors in the applied
neuropsychological tasks was 7 % at the maximum in
previous studies. Taking this and a potential dropout
rate of 25 % into account, a minimum of 53 patients
must be included. Thus, we will recruit 27 patients for
each group (total n = 54).
Intervention
Patients in the real CBM condition will conduct a treat-
ment version of the Food Approach-Avoidance Task
(Food-AAT) [39]. In this task, participants are shown
colour photographs of food and control (i.e. neutral
household and office) items on a computer screen. They
are required to pull or push a joystick in response to the
outline of the picture (round versus rectangular), irre-
spective of picture content. Format movement assign-
ments are counterbalanced among participants (i.e. half
will push round pictures and half will push rectangular
pictures). When the joystick is pulled, the picture grows
bigger and when it is pushed it grows smaller. This
zooming-in and zooming-out emphasises respective
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sensations of approaching and avoiding and thus com-
bines the proprioceptive (arm movement) and exterocep-
tive (zooming feature) cues of approach and avoidance
behaviour [47]. The treatment version of the Food-AAT
adopts an implicit learning paradigm by presenting all
food pictures in the ‘push’ (i.e. avoid) format so that
participants learn to link avoidance movements to visual
cues of high-calorie food. Patients will receive ten 15-min
sessions of training over a 4-week period.
Patients in the control condition (sham CBM) will
receive the same dosage of the same task but will not be
trained to avoid food cues in the Food-AAT. Instead,
Fig. 1 Participant flow chart
Table 1 ABBA study schedule of enrolment, interventions and assessments
Study period
Treatment (real CBM) group and control (sham CBM) group Control group
only (optional)
Enrolment Pre-allocation Allocation Treatment Post- treatment Treatment
Timepoint 0 Baseline assessment (t1) 0 Weeks 1 –4 Follow-up (t2) 2- month follow-up (t3) Weeks 1–4
Enrolment:
Eligibility screen X
Informed consent X
Allocation X
Interventions:
Real CBM 10 x 10 x
Sham CBM 10 x
Assessments:
Weight X
Questionnaires X X
Computer tasks X X
Taste Test X X
Clinical interview X X
CBM cognitive bias modification
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patients in the control condition receive 10 additional
sessions of the pre- and post-treatment assessment
version of the task (Food-AAT), which requires an equal
number of approach and avoidance movements to both
food and non-food pictures. Sham (placebo) CBM with
an equal dosage, frequency and character was chosen as
the comparator treatment in order to examine the
specific effects of this form of CBM.
Sessions will take place in dedicated research facilities.
In line with the vulnerability-stress model of cognitive
biases described in the introduction [48], participants
will be presented with a set of pictures that are consid-
ered to induce mild levels of negative mood at the be-
ginning of every training session (60 images; duration:
approximately 1 min) [49].
Study adherence: a researcher will be present through-
out the training and assessment sessions to ensure study
adherence. The interventions are predefined, compu-
terised tasks. Any deviation from the study protocol will
be recognised and recorded immediately. We will ask par-
ticipants to refrain from any other treatment that focuses
on their eating disorder. However, if clinical need dictates
another treatment, this will be documented but will not
lead to the exclusion of the participant. Participants are
allowed to discontinue the treatment at any time.
Procedure
A flowchart outlining the study procedures is presented in
Fig. 1. For further information about the time schedule of
enrolment, interventions and study assessments, please
see Table 1.
Screening
Potential participants will be referred to the study by their
clinician or by themselves. Study researchers will screen
participants for eligibility. Screening includes the Struc-
tured Clinical Interview for DSM Disorders (SCID)
[50–52], a short inclusion/exclusion screen specific to this
study, and an assessment of medical and psychiatric his-
tory and medication dosage and stability. In line with the
Consolidated Standards of Reporting Trials (CONSORT)
guidelines, we will record the number and reasons for any
participants we must exclude, or any who decline consent
or withdraw from the study.
Baseline assessment
Binge-eating frequency and general eating disorder
symptomatology will be assessed in terms of a spe-
cific, structured clinical interview, i.e. the Eating Dis-
orders Examination [53, 54]. Participants will also be
weighed and asked to complete a battery of question-
naires relating to eating disorder symptomatology, food
craving, depression and anxiety, as well as neuropsycho-
logical computer tasks that assess approach bias and
attentional bias towards visual food cues and working
memory. Furthermore, state levels of food craving after
cue exposure and food intake will be assessed in labora-
tory tasks.
Once the baseline assessment is completed, participants
will be randomly allocated to the treatment (real CBM) or
control (sham CBM) group. Randomisation will be per-
formed independently from the trial team by a central study
office at Heidelberg University Hospital. The first CBM ses-
sion will start on the day of the baseline assessment. Partici-
pants in the sham group will be offered the opportunity to
receive real CBM after the end of follow-up.
Post-treatment assessment
The post-treatment assessment will take place after the
last training session, and will include the same elements
as the baseline assessment except for the Eating
Disorders Examination.
Two-month follow-up
Two months after the post-treatment assessment a
follow-up session will be conducted which will involve
the Eating Disorders Examination. Finally, the success of
blinding will be evaluated by asking participants to guess
the treatment allocation. Participants will be unmasked
and individuals in the control group will then be offered
the real treatment.
Measures
Screening measures
▪ Body Mass Index (kg/m2)
▪ Screening module of the SCID [50–52]: this
semistructured psychiatric interview will be used as a
diagnostic screen to assess the presence of psychiatric
comorbidities.
▪ The depression module of the Patient Health
Questionnaire (PHQ-9) [55, 56] and the General Anxiety
Disorder Screener-7 (GAD-7) [57, 58] are reliable and
valid as well as widely used self-report instruments to
assess symptoms of depression and anxiety according to
the DSM-5.
Primary outcome measure
▪ Eating Disorder Examination (EDE) [53, 54]: the
primary outcome variable in this study is the treatment-
specific change from baseline to 2-month follow-up in
the number of objective binge-eating episodes as
assessed by the EDE. The EDE is a reliable and valid as
well as widely used measure of eating disorder symp-
toms and is regarded as the instrument of choice for the
assessment and diagnosis of eating disorders according
to the DSM-5.
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Secondary outcome measures
▪ Food Approach-Avoidance Task (Food-AAT),
assessment version [16, 39, 59]: this task will be used to
assess approach bias towards visual cues of high-calorie
food (expected target cognitive mechanism of interven-
tion). It is identical to the treatment version except that
in the assessment version of the task, the required
response is unrelated to the picture content (i.e. food and
neutral stimuli are presented equally often in round and
rectangular, i.e. push and pull, format). The approach
bias towards food is calculated by subtracting the me-
dian reaction time (RT) for pulling food pictures from
the median RT for pushing pictures of this category
[59]. Thus, a positive value denotes an approach bias
(i.e. the participant is faster in pulling than in pushing
food pictures), whereas a negative value indicates an
avoidance bias.
▪ Visual probe task [60]: this task will be used to assess
participants’ attentional bias towards visual food cues.
During this computer task picture pairs (food/non-food)
are presented side by side on a computer screen after the
presentation of a fixation point at the centre of the
screen and are followed by the presentation of a probe
(denoted by *) appearing in the location of one of the
pictures. Participants are instructed to indicate the
location of the probe by pressing a corresponding key
on a keyboard as quickly as possible. The position of
the food and neutral pictures are balanced across trials
so that each appears in either location with equal
frequency. Recordings of the participant’s manual
response latency when indicating the location of the
probe are used to calculate a response latency bias. The
logic of this task presumes that participants who have an
attention bias towards food are quicker in responding to
indicate the location of the probe when the probe
replaces a food stimulus. Thus, the latencies of manual
responses provide an index for attention bias for food.
Positive values indicate faster mean latencies (i.e. an
attentional bias) to food cues than for neutral cues.
▪ The Food Challenge Task [16, 39, 61]: the Food
Challenge Task will be used to examine cue-induced
food craving. Participants rate their state levels of food
craving using the Food Cravings Questionnaire State
Version [62, 63] after being presented with filmed cues
of highly appetitive foods.
▪ Taste Test: food intake will be measured by means of a
‘Taste Test’. Participants will be instructed to rate three
bowls of highly palatable food items (chocolate, crisps,
fruit gums) in terms of their visual attractiveness, smell
and taste. The participants will be told that they are free
to try as much of the offered items as they like.
Consumption will be determined by weighing the bowls
both before and after the Taste Test.
▪ The digit-span forward and backward subtests of the
Wechsler Memory Scale III [64] will be used to measure
working memory capacity.
▪ Global eating disorder psychopathology will be
assessed by the EDE [53, 54].
▪ The Food Cravings Questionnaire Trait Version [62,
63]: this is a reliable and valid self-report questionnaire
that measures trait levels of craving for food.
▪ Treatment acceptance will be assessed using a
feedback form composed of several standard questions
regarding the acceptance of the intervention [39].
Confidentiality and anonymity of all personal data will
be retained throughout the entire study. Manual files
will be securely locked in a lockable filing cabinet and all
electronic files will be password-protected. Identifying
information will be removed from the data, stored separ-
ately and replaced with a numeric identification code.
The master list of names which correspond to each
participant’s numeric identification code will be stored
electronically and will be password-protected. This
information will only be accessible to key researchers
involved in the study.
Randomisation
Randomisation will be performed independently from
the trial team by a central study office at Heidelberg
University Hospital using a specific randomisation soft-
ware (RANDI2). Randomisation will be stratified for BN
and BED in a 1:1 ratio. Participants in the sham group
will be offered the opportunity to receive real CBM after
the end of follow-up.
Blinding
Participants and assessors using the EDE will be blinded
to treatment allocation throughout, i.e. the study will be
conducted in a double-blind fashion. To assess whether
allocation concealment has been successful, participants
will be asked to guess the treatment allocation at the
end of treatment and to indicate how certain they are of
this guess. Participants will be debriefed and unblinded
to group allocation upon completion of the 2-month
follow-up.
Analyses
To determine quality, completeness and variability of
the outcome measures, descriptive statistical analyses
and graphical methods will be used. To evaluate
treatment-specific changes over time in patients, a 2 × 2
repeated measures ANOVA, with group as between-
subject factor and time as within-subject factor, will be
applied. The size of the treatment effect on the outcome
measure (EDE) will be the difference in outcome data
between those in the two treatment conditions at
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follow-up. Additionally, multiple regression models will
permit exploration of the relationship between changes
in the cognitive measures and symptom improvement.
No interim analyses are planned. A two-tailed signifi-
cance level of p < .05 will be used throughout. Both com-
pleter and intent-to-treat analyses will be performed.
Missing values will be replaced by using the Last Obser-
vation Carried Forward (LOCF) method for the intent-
to-treat analysis. As this is a pilot trial resources do not
stretch to setting up a Monitoring Committee. Analyses
will be conducted by the principal investigators. As
CBM is a safe procedure with no known side effects we
do not expect any unexpected adverse reactions, serious
or unexpected serious adverse reactions. We will report
any adverse reactions and serious adverse events. It is
intended that the results of the study will be reported
and disseminated by the principal investigators at inter-
national conferences and in peer-reviewed scientific
journals.
Discussion
The ABBA study aims to examine the potential of a
novel, computerised, short-term treatment module for
patients with bulimic eating disorders that targets a
specific cognitive bias in the processing of visual food
cues, i.e. automatic approach tendencies towards highly
palatable food. This is the first study examining this
treatment approach in a clinical sample of patients with
BN and BED. Particularly in view of the high attrition
and relapse rates in bulimic eating disorders, novel treat-
ment approaches are urgently needed [4, 65]. Strengths
of the presented study include a rigorous, double-blind,
randomised controlled design including a strong control
condition with a similar task and equal dosage, and the
assessment of potential action mechanisms. Several
potential practical and operational issues, however, may
pose challenges to the successful and timely completion
of the study, particularly regarding recruitment and
attrition. Patients with eating disorders are often
ambivalent about treatment, which is reflected in high
attrition rates and this may become particularly difficult
if a participant believes that they are receiving sham
treatment, or if the treatment and assessments are expe-
rienced as too burdensome.
Trial status
Participant recruitment and data collection have already
begun by the time of manuscript submission.
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